Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

45.34
Delayed Data
As of Aug 17
 -1.07 / -2.31%
Today’s Change
30.89
Today|||52-Week Range
47.98
+26.44%
Year-to-Date

Stock Price Forecast

The 31 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 45.77, with a high estimate of 55.24 and a low estimate of 31.73. The median estimate represents a +0.96% increase from the last price of 45.34.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Hold stock in Novo Nordisk. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.59
Sales
$4.3B
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.00%
 
 
 
 
 
 
Growthannually 13.52%
 
 
 
 
 
 

Sales

Growthquarterly -4.03%
 
 
 
 
 
 
Growthannually 11.94%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.